NCT07255664 2025-12-08
ProbeTILity
Curacell Holding AB
Phase 1/2 Recruiting
Clinical Trials
5 trialsNCT05881525 2025-07-16
NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors
TCRCure Biopharma Ltd.
Phase 1 Recruiting
NCT06119685 2025-06-03
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Indapta Therapeutics, INC.
Phase 1/2 Recruiting
NCT06302062 2024-12-03
TAL-T
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1 Recruiting
NCT03891706 2024-09-19
Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1 Recruiting